在PCI期间辅助冠状动脉血栓切除术:一个单个中心的回顾性现实世界经验
António Rocha de Almeida1, Rita Louro1, David Neves1
1Division of Cardiology of Hospital Espírito Santo de Évora, Unidade Local de Saúde Alentejo Central, Évora, Portugal.
概括
穿皮冠状动脉干预 (PCI) 期间的选择性冠状动脉血栓切除术对于高血栓负担,特别是STEMI患者来说是安全的. 当明智地使用时,它不会增加中风或死亡风险,支持PCI的个性化决策.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 血管医学 血管医学
背景情况:
- 冠状动脉血栓切除术在穿皮冠状动脉干预 (PCI) 中的作用是有争议的,因为研究结果和关于中风风险的担忧相互矛盾.
- 尽管存在争议,但血栓切除术是一种简单的技术,在特定的高血栓状情景中具有价值.
- 这项研究评估了PCI期间选择性冠状动脉血栓切除术的现实安全性和有效性.
研究的目的:
- 在接受PCI的患者中评估选择性冠状动脉血栓切除术的安全性和有效性.
- 为了比较结果,包括脑血管事件和手术成功,在接受血栓切除术和没有接受血栓切除术的患者之间.
- 评估血栓切除术在现实世界,单中心环境中的实用性,特别是在急性冠状动脉综合征 (ACS) 患者中.
主要方法:
- 一个回顾性队列研究2658连续患者与ACS接受PCI从2016年到2024年.
- 根据PCI期间是否接受辅助冠状动脉血栓切除术,患者被划分为几组.
- 关键的终点包括脑血管事件 (中风,TIA),手术成功,并发症和死亡率,在不同组之间进行比较.
主要成果:
- 接受血栓切除术的患者年轻,患STEMI和更高基利普等级的可能性更高.
- 冠状动脉血栓切除术是安全的,脑血管事件的比率 (0.6%对0.4%) 和手术死亡率 (1%对0.5%) 在两组之间相似.
- 术后的并发症,特别是不回流,在血栓切除组中更为频繁 (5%与2%相比).
结论:
- 常规冠状动脉血栓切除术不建议,但对高血栓负担患者 (特别是STEMI) 的选择性使用得到了现实数据的支持.
- 经验丰富的操作人员的审慎使用与中风或程序性死亡风险的增加无关.
- 血栓切除术在当代PCI中仍然是一个有价值的工具,当它与临床判断和个性化决策一起应用时.
更多相关视频
28:13Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
33.5K
08:00Reduction of Iatrogenic Atrial Septal Defects with an Anterior and Inferior Transseptal Puncture Site when Operating the Cryoballoon Ablation Catheter
Published on: June 15, 2015
14.0K
相关概念视频
01:30Acute Coronary Syndrome III: Diagnostic Studies
26
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
26
01:27Coronary Artery Disease V: Interprofessional Care
39
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
39
01:26Coronary Artery Disease IV: Preventive Measures
39
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
39